Skip to content
Home / Pubblicazioni / Pubblicazioni scientifiche

Pubblicazioni scientifiche

 Pubblicazioni scientifiche del Registro Tumori Veneto.

Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study

Buja A, Bardin A, Damiani G, Zorzi M, De Toni C, Fusinato R, Spina R, Vecchiato A, Del Fiore P, Mocellin S, Baldo V, Rugge M, Rossi CR. Front Oncol. 2021 Nov 16;11:737399. doi: 10.3389/fonc.2021.737399. eCollection 2021. Abstract Introduction: Among white people, the incidence of cutaneous malignant melanoma (CMM) has been increasing steadily for several decades. Meanwhile, there has also been a significant improvement in 5-year survival among patients with melanoma. This population-based cohort study investigates the five-year melanoma-specific survival (MSS) for all melanoma cases recorded...

Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort

Trama A, Tittarelli A, Barigelletti G, Botta L, Gatta G, Tagliabue G, Contiero P, Guzzinati S, Andreano A, Manneschi G, Falcini F, Castaing M, Filiberti RA, Gasparotti C, Cirilli C, Mazzucco W, Mangone L, Iacovacci S, Vitale MF, Stracci F, Piffer S, Tumino R, Carone S, Sampietro G, Melcarne A, Ballotari P, Boschetti L, Pisani S, Cavalieri D'Oro L, Cuccaro F, D'Argenzio A, D'Orsi G, Fanetti AC, Ardizzone A, Candela G, Savoia F, Pascucci C, Castelli M, Storchi C, Bernasconi A. Cancer. 2021 Sep 28. doi: 10.1002/cncr.33931. Online ahead of print. Abstract Background: Evidence about late effects...

Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012

Crocetti E, Mattioli V, Buzzoni C, Franceschi S, Serraino D, Vaccarella S, Ferretti S, Busco S, Fedeli U, Varvarà M, Falcini F, Zorzi M, Carrozzi G, Mazzucco W, Gasparotti C, Iacovacci S, Toffolutti F, Cavallo R, Stracci F, Russo AG, Caldarella A, Rosso S, Musolino A, Mangone L, Casella C, Fusco M, Tagliabue G, Piras D, Tumino R, Guarda L, Dinaro YM, Piffer S, Pinna P, Mazzoleni G, Fanetti AC, Dal Maso L; for AIRTUM working group. Cancer Med. 2021 Sep 17. doi: 10.1002/cam4.4193. Online ahead of print. Abstract Background: The number of patients living after a cancer diagnosis is increasing,...

SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study

Zorzi M, Guzzinati S, Avossa F, Fedeli U, Calcinotto A, Rugge M. Front Oncol. 2021 Oct 11;11:730131. doi: 10.3389/fonc.2021.730131. eCollection 2021. Abstract Aim: In a consecutive series of cancer patients tested for SARS-CoV-2 infection, this retrospective population-based study investigates the risks of viral infection and death. Methods: Malignancies were distinguished as incident or prevalent (active or inactive). Cancer management and vital status were retrieved from institutional regional databases. Comorbidities were recorded, based on Adjusted Clinical Groups (ACG). Six Resource...

Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study

Massari M, Spila-Alegiani S, Fabiani M, Belleudi V, Trifirò G, Kirchmayer U, Poggi FR, Mancuso P, Menniti-Ippolito F, Gini R, Bartolini C, Leoni O, Ercolanoni M, Da-Re F, Guzzinati S, Luxi N, Riccardo F, Giorgi-Rossi P. Vaccines (Basel). 2021 Jul 1;9(7):716. doi: 10.3390/vaccines9070716. AbstractTo investigate the association of the 2019-2020 influenza vaccine with prognosis of patients positive for SARS-CoV-2A, a large multi-database cohort study was conducted in four Italian regions (i.e., Lazio, Lombardy, Veneto, and Tuscany) and the Reggio Emilia province (Emilia-Romagna). More than 21...

Colorectal cancer incidence and mortality after negative fecal immunochemical tests by age 70: A prospective observational study

Zorzi M, Battagello J, Fiore AR, Memo L, Senore C, Rugge M. Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33682. Online ahead of print.  Abstract Limited endoscopy capacity usually represents the main barrier to the extension of screening to subjects older than 70, given the high positivity rate in this age group. We assessed CRC incidence and mortality by number of previous negative fecal immunochemical tests (FIT) among subjects turning 70. We selected persons aged 70 years who had received their last screening invitation when they were 68 or 69 years old within the population-based...

Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy

Alegiani SS, Crisafulli S, Rossi PG, Mancuso P, Salvarani C, Atzeni F, Gini R, Kirchmayer U, Belleudi V, Kurotschka PK, Leoni O, Ludergnani M, Ferroni E, Baracco S, Massari M, Trifirò G; ITA-COVID-19 Network. Rheumatology (Oxford). 2021 Apr 15:keab348. doi: 10.1093/rheumatology/keab348. Online ahead of print.  Abstract Objectives: To ascertain if hydroxychloroquine (HCQ)/chloroquine (CLQ) and other conventional disease-modifying anti-rheumatic drugs (cDMARDs) use, and rheumatic diseases per se, may be associated with COVID-19-related risk of hospitalization and mortality. Methods: This...

Argomenti in evidenza

Pubblicazioni scientifiche

 Pubblicazioni scientifiche del Registro Tumori Veneto.

Monografie

 Report per sede tumorale e monografie.

Congressi e conferenze

Scopri tutte le pubblicazioni orali e i poster.